New study shows potential determinate for thyroid cancer severity

Researchers at the University of Toronto and Mount Sinai Hospital recently used technology to discover proteins that are secreted by thyroid cancer cells, in order to identify potential biomarkers for the future management of thyroid tumors.

The study, which was published in the Journal of Proteome Research, may be beneficial to physicians because these biomarkers have the potential to aid oncologists in determining the aggressiveness of a cancer so appropriate treatment plans can be developed for patients, Health Canal reports.

"We know that about 10 to 15 percent of thyroid cancers are aggressive," said Professor Emeritus Paul Walfish, an endocrinologist at Mount Sinai Hospital and senior author of the study. "Our hope is that out of this research, a diagnostic test can be developed that will allow us to detect aggressive forms of the cancer early so we create rigorous treatment plans that will help improve outcomes for patients."

According to the National Cancer Institute, there are 19,500 thyroid cancer diagnoses in the U.S. annually.